4//SEC Filing
Janssen Robert 4
Accession 0001209191-24-003546
CIK 0001029142other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:43 PM ET
Size
8.1 KB
Accession
0001209191-24-003546
Insider Transaction Report
Form 4
Janssen Robert
Chief Medical Officer and VP
Transactions
- Award
Stock Options (Right to Buy)
2024-02-15+50,000→ 50,000 totalExercise: $12.48Exp: 2031-02-15→ Common Stock (50,000 underlying) - Award
Restricted Stock Unit
2024-02-15+35,710→ 35,710 total→ Common Stock (35,710 underlying)
Footnotes (3)
- [F1]Code A: Grant, award or other acquisition
- [F2]This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 15, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
- [F3]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.
Documents
Issuer
DYNAVAX TECHNOLOGIES CORP
CIK 0001029142
Entity typeother
Related Parties
1- filerCIK 0001580849
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:43 PM ET
- Size
- 8.1 KB